Abstract
The aim of this contribution is to review the radio-oncological rationale of heavy ion beam radiotherapy in the management of cancer. Protons and helium ions are being investigated because of the improved dose distributions, perhaps superior in many clinical situations to those obtainable with photons or electrons. Heavy ions also bear the advantage of superior dose distribution and may additionally provide higher biological effectivity. A substantial database of historical results supports the hypothesis that conformal radiotherapy is superior to conventional radiotherapy. For the selection of patients for ion beam therapy, the following questions have to be evaluated: Can any significant radiation morbidity by conventional treatment expected? Is the radiation morbidity caused by unintended irradiation of non-target tissue outside the planning target volume? Can the tumor control be improved due to dose escalation with less radiation morbidity? A substantial number of patients have been treated by light ion radiotherapy. There are only a few clinical trials attempting to compare conventional photon radiotherapy with light ion radiotherapy. Clinical results with heavy ions such as carbon ions seem very promising in certain tumors. However results of randomized trials are still to be seen. Clearly the control arm has to be designed to be as close as possible to the optimal photon/electron treatment methods in use. The feasibility of heavy ion treatment has been demonstrated worldwide, with more than 10000 patients. In the near future more centers worldwide will start patient treatments. The wider availability of light ion beams for clinical use will enable the establishment of a database of clinical results and the elucidation of the role of heavy ion beams in the treatment of cancer.
It has been shown in previous chapters that there may be a clinical benefit of high-linear energy transfer (LET) radiotherapy compared to low-LET radiotherapy. The aim of this contribution is to review the radio-oncologic rationale of ion beam radiotherapy in cancer management.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Austin-Seymour M, Munzenrider JE, Goitein M, Gentr R, Gragoudas E, Köhler P, McNulty P, Osborne B, Ryugo DK, Seddon J, Urie M, Verhey L, Suit H (1985) Progress in low-LET heavy particle therapy: intracranial and paracranial tumors and uveal melanomas. Radiat Res 104: S219–S226
Castro JR, Linstadt DB, Bahary JP, Petti PL, Daftari I, Collier JM, Gutin PH, Gauger GE, Philipps TL (1994) The experience in charged particle irradiation of tumors of the skull base: 1977–1992. Int J Radiat Oncol Biol Phys 23: 647–655
Char DH, Quivey JM, Castro JR, Kroll S, Phillips T (1993) Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 100: 1547–1554
Debus J, Hug EB, Liebsch NJ, O’Farrel D, Finkenstein D, Efird J, Munzenrider LE (1997) Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys 39 (5): 967–975
Drumm K (1993) Sozioökonomische Studie zur Strahlentherapie mit geladenen Partikeln. Thesis, Rupprecht-Karls University, Heidelberg
Egger E, Zografos L (1994) Proton beam irradiation of uveal melanomas at PSI: latest results. In: Amaldi U, Larson B (eds) Hadron therapy in oncology. Elsevier, Amsterdam, pp 145–145
Engenhart R, Kimmig BN, Hover KH, Wowra B, Romahn J, Lorenz WJ, van Kâick G, Wannenmacher M (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71: 1353–1361
Field SB, Fowler JF (1984) The biological basis for neutron therapy. J Eur Radiother 5: 170–175
Gademann G, Wannenmacher M (1992) Charged particle therapy to pediatric tumors of the retroperitoneal region: a possible indication. Int J Radiat Oncol Biol Phys 22: 375–381
Goitein M (1992) 3D treatment planning for heavy charged particles. Radiat Environ Bio-phys 31:241–245
Griffin TW, Krall JM, Laramore GB, Parker RG, Burnison M, Peters LJ, Maor M, Zink S, Davis LW, Russell KJ (1993) Fast neutron irradiation of prostate cancer: the results of a cooperative, phase III randomized study (Abstr). Int J Radiat Oncol Biol Phys 27 Suppl 1: 247
Griffin TW, Wambersie A, Laramore G, Castro J (1994) High LET: heavy particle trials. Int J Radiat Oncol Biol Phys 14 51: S83–S93
Hall EJ, Kraljevic J (1976) Repair of potentially lethal radiation damage: comparison of neutron and X-ray RBE-implications for radiation therapy. Radiology 121: 731
Linstadt DB, Castro JR, Phillips TL (1991) Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys 20: 761–769
Meecham WJ, Char DH, Kroll S, Castro JR, Blakely EA (1994) Anterior segment complications after helium ion radiation therapy for uveal melanoma. Radiation cataract. Arch Ophthalmol 112: 197–203
Munzenrider JE (1994) Proton therapy with the Harvard cyclotron. In: Amaldi U, Larson B (eds) Hadron therapy in oncology. Elsevier, Amsterdam, pp 83–101
Schoenthaler R, Castro JR, Halberg FE, Phillips TL (1993) Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photos. Int J Radiat Oncol Biol Phys 27: 75–82
Suit HD (1988) The scope of the problem of primary tumor control. Cancer 61: 2141–2147
Suit H (1992) Potential for proton beams in clinical radiation oncology. In: Dewey WC, Edington M, Fry RJM, Hall BJ, Whitmore GF-(eds) Radiation research. A twentieth cen-tury perspective, vol 2. Academic, San Diego, pp 3–13
Uhl V, Castro JR, Knopf K, Phillips TL, Collier JM, Petti PL, Daftari I (1992) Preliminary results in heavy charged particle irradiation of bone sarcoma. Int J Radiat Oncol Biol Phys 24: 755–759
Zimmermann LE, McLean IW (1975) Changing concepts concerning the malignancy of ocular tumors. Arch Opthalmol 78: 487
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Debus, J., Jäckel, O., Kraft, G., Wannenmacher, M. (1998). Is There a Role for Heavy Ion Beam Therapy?. In: Engenhart-Cabillic, R., Wambersie, A. (eds) Fast Neutrons and High-LET Particles in Cancer Therapy. Recent Results in Cancer Research, vol 150. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78774-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-78774-4_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78776-8
Online ISBN: 978-3-642-78774-4
eBook Packages: Springer Book Archive